Skip to main content

Myocardial Oxygen Consumption in Patients with Idiopathic Dilated Cardiomyopathy: Effects of Vasodilating and Inotropic Agents

  • Conference paper
Idiopathic Dilated Cardiomyopathy
  • 108 Accesses

Abstract

Idiopathic dilated cardiomyopathy is a myocardial disease of unknown origin. Several causal factors are discussed. One hypothesis involves energy depriviation in the failing myocardium, and a number of arguments exist for such an energy-starving situation [22, 23]. These include the following: (a) In some studies investigating the energy state of hypertrophied and failing myocardium, a reduced content of high energy phosphates was reported [5, 39]. However, these findings were not confirmed by others [33, 34]. (b) In the failing human myocardium, a reduction in myofibrillar ATPase activity [1, 25, 30] and a shift of the isoenzyme pattern of lactate dehydrogenase [36] has been observed. Both changes may be interpreted in terms of adaptation to energy depletion; reduced myofibrillar ATPase activity is associated with more economical tension development, as shown in mammalian myocardium [2, 15, 16] and in human myocardium [14], and the shifts in the isoforms of the lactate dehydrogenase are indicators of anaerobic glycolysis [36]. (c) A reduction in capillary density may lead to increased diffusion distances [4]. (d) A reduced ratio of mitochondria and myofibrillar volumes indicates a mismatch between the number of ATP synthesizing sites and the number of ATP consuming sites [4, 31]. (e) Reduced coronary reserve has been observed in patients with dilated cardiomyopathy using the dipyridamole test [28, 29, 32].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alpert NR, Gordon MS (1962) Myofibrillar adenosine triphosphatase activity in congestive heart failure. Am J Physiol 202:940–946

    PubMed  CAS  Google Scholar 

  2. Alpert NR, Mulieri LA (1982) Increasing myothermal economy of isometric force genera- tion in compensated cardiac hypertrophy induced by pulmonary artery constriction in rabbit. A characterization of heat liberation in normal and hypertrophied papillary muscle. Circ Res 50:491–500

    PubMed  CAS  Google Scholar 

  3. Amin DK, Shah PK, Hulse S, Shellock FG, Swan HJC (1984) Myocardial metabolic and hemodynamic effects of intravenous MDL 17043, a new cardiotonic drug in patients with severe heart failure. Am Heart J 108:1285–1292

    Article  PubMed  CAS  Google Scholar 

  4. Anversa P, Olivetti C, Melissari M, Loud AV (1980) Stereological measurement of cellular and subcellular hypertrophy and hyperplasia in the papillary muscle of the adult rat. J Moll Cell Cardiol 12:781–795

    Article  CAS  Google Scholar 

  5. Bashore TM, Magorien DJ, Letterio J, Shaffer P, Unverferth DV (1987) Histologic and biochemical correlates of the left ventricular chamber dynamics in man. J Am Coll Cardiol 9:734–742

    Article  PubMed  CAS  Google Scholar 

  6. Braunwald E (1971) Control of myocardial oxygen consumption: physiologic and clinical considerations. Am J Cardiol 27:416–432

    Article  PubMed  CAS  Google Scholar 

  7. Cohn JN, Archibald DG, Ziesche S et al. (1986) Effects of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 314:1547–1552

    Article  PubMed  CAS  Google Scholar 

  8. CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316:1429–1435

    Article  Google Scholar 

  9. Dies F, Krell MJ, Whitlow P, Liang C-S, Goldenberg I, Applefeld MM, Gilbert EM (1986) Intermittent dobutamine in ambulatory outpatients with chronic cardiac failure. Circulation 74 [Suppl II]:152

    Google Scholar 

  10. Dubiel IS, Dubiel IP, Frendo J, Zmudka K, Horzela T (1986) Coronary circulation and myocardial metabolism in dilated cardiomyopathy. Cor Vasa 28:356–364

    PubMed  CAS  Google Scholar 

  11. Graham TP, Covell JW, Sonnenblick EH, Ross J Jr, Braunwald E (1968) Control of myocardial oxygen consumption: relative influence of contractile state and tension development. J Clin Invest 47:375–385

    Article  PubMed  Google Scholar 

  12. Hasenfuss G, Holubarsch C, Heiss HW, Bonzel T, Funfack M, Revenaugh M, Meinertz T, Just H (1987) Hemodynamics and myocardial oxygen metabolism of pulsus alternans in patients with dilated cardiomyopathy. Clin Cardiol 10:223–327

    Google Scholar 

  13. Hasenfuss G, Holubarsch C, Heiss HW, Meinertz T, Bonzel T, Wais U, Lehmann M, Just H (1989) Myocardial energetics in patients with dilative cardiomyopathy. Influence of nitroprusside and enoximone. Circulation 80:51–64

    Article  PubMed  CAS  Google Scholar 

  14. Hasenfuss G, Mulieri LA, Blanchard EM, Holubarsch C, Leavitt BJ, Ittleman F, Alpert NR (1991) Energetics of isometric force development in control and volume-overload human myocardium. Comparison with animal species. Circ Res 68:836–846

    PubMed  CAS  Google Scholar 

  15. Holubarsch C, Goulette RP, Mulieri LA, Alpert NR (1983) Heat liberation in experimentally induced tetanic contractions of myocardium from normal and Goldblatt rats. In: Jacob R (ed) Cardiac adaptation of hemodynamic overload, training and stress. Steinkopff, Darmstadt, pp 158–166

    Google Scholar 

  16. Holubarsch C, Litten RZ, Mulieri LA, Alpert NR (1985) Energetic changes of myocardium as an adaptation to chronic hemodynamic overload and thyroid gland activity. Basic Res Cardiol 80:582–593

    Article  PubMed  CAS  Google Scholar 

  17. Holubarsch C, Hasenfuss G, Heiss HW, Meinertz T, Just H (1987) Acute and chronic changes of myocardial energetics in the mammalian and human heart. Basic Res Cardiol 82 [Suppl II]:377–388

    PubMed  Google Scholar 

  18. Holubarsch C, Hasenfuss G, Just H, Blanchard E, Mulieri LA, Alpert NR (1989) Influence of the positive inotropic substance pimobendane (UDCG 115 BS) on contractile economy of guinea pig papillary muscles. J Cardiovasc Pharmacol 14 [Suppl 2]:S13-S17

    PubMed  CAS  Google Scholar 

  19. Holubarsch C, Hasenfuss G, Blanchard E, Mulieri LA, Alpert NR (1989) Influence of the phosphodiesterase inhibitor E-1020 on mechanics and energetics in guinea pig papillary muscles. Circulation 80 [Suppl II]:612

    Google Scholar 

  20. Holubarsch C, Hasenfuss G, Just H, Blanchard EM, Mulieri LA, Alpert NR (1990) Modulation of myothermal economy of isometric force generation by positive inotropic interventions in the guinea pig myocardium. Cardioscience 1:33–41

    PubMed  CAS  Google Scholar 

  21. Holubarsch Ch, Hasenfuss G, Thiefelder L, Just H (1991) Energetic consequences of substances currently used or recommended for long-term treatment of chronic heart failure. Bas Res Cardiol 86, Suppl I:107–112

    Google Scholar 

  22. Katz AM (1986) Potential deleterious effects of inotropic agents in the therapy of chronic heart failure. Circulation 73 [Suppl III]: 184–188

    Google Scholar 

  23. Katz AM (1989) Energy requirements of contraction and relaxation: implications for inotropic stimulation of the failing heart. Basic Res Cardiol 84 [Suppl I]:47–53

    Article  PubMed  Google Scholar 

  24. Laskey WK, Reichek N, Sutton MS, Untereker WJ, Hirshfeld JW (1983) Myocardial oxygen consumption in left ventricular hypertrophy and its relation to left ventricular mechanics. Am J Cardiol 52:852–858

    Article  PubMed  CAS  Google Scholar 

  25. Leclerque JF, Swynghedauw B (1976) Myofibrillar ATPase, DNA and hydroxyproline content of human hypertrophied heart. Eur J Clin Invest 6:27–33

    Article  Google Scholar 

  26. Martin JL, Likoff MJ, Janicki JS, Laskey WK, Hirshfeld JW, Weber KT (1984) Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failure. J Am Coll Cardiol 4:875–883

    Article  PubMed  CAS  Google Scholar 

  27. Mirsky I (1979) Elastic properties of the myocardium: a quantitative approach with physiological and clinical applications. In: Berne RM (ed) Handbook of physiology. The cardiovascular system. American Physiological Society, Washington, pp 497–531

    Google Scholar 

  28. Nitenberg A, Foult IM, Blanchet F, Zonioneche S (1985) Multifactorial determinants of reduced coronary flow reserve after dipyridanole in dilated cardiomyopathy. Am J Cardiol 55:748–754

    Article  PubMed  CAS  Google Scholar 

  29. Opherk D, Schwarz F, Mall G, Manthey J, Baller D, Kuebler W (1983) Coronary dilator capacity in idiopathic dilated cardiomyopathy: analysis of 16 patients. Am J Cardiol 51:1657–1662

    Article  PubMed  CAS  Google Scholar 

  30. Pagani ED, Alousi AA, Grant AM, Order TM, Dziuban SW, Allen PD (1988) Changes in myofibrillar content and Mg-ATPase activity in ventricular tissue from patients with heart failure caused by coronary artery disease, cardiomyopathy, or mitral valve insufficiency. Circ Res 63:380–385

    PubMed  CAS  Google Scholar 

  31. Page E, McCalister LP (1973) Quantitative electron microscopic description of heart muscle cells. Application to normal, hypertrophied, and thyroxin-stimulated heart. Am J Cardiol 31:172–181

    Article  PubMed  CAS  Google Scholar 

  32. Pasternac A, Noble J, Streulens Y, Elie R, Heuschke C, Bourassa MG (1982) Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries. Circulation 65:778–789

    Article  PubMed  CAS  Google Scholar 

  33. Regitz V, Rappolder M, Bossaller C, Strasser R, Fleck E (1990) Myocardial ATP, ADP and AMP in heart failure of different origins. Eur Heart J 11[Suppl]:189

    Google Scholar 

  34. Regitz V, Fleck E (1992) Adenine nucleotide metabolism and contracile dysfunction in heart failure. Basic Res Cardiol 87, Suppl I:321–329

    PubMed  CAS  Google Scholar 

  35. Rooke GA, Feigl EO (1982) Work as a correlate of canine left ventricular oxygen consumption, and the problem of catecholamine oxygen wasting. Circ Res 50:273–286

    PubMed  CAS  Google Scholar 

  36. Schultheiss HP (1990) Effect on the myocardial energy metabolism of angiotensin- converting enzyme inhibition in chronic heart failure. Am J Cardiol 65:G74-G81

    Article  Google Scholar 

  37. SOLVD investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection farctions and congestive heart failure. N Engl J Med 325:293–302

    Google Scholar 

  38. Strauer BE (1979) Ventricular function and coronary hemodynamics in hypertensive heart disease. Am J Cardiol 44:999–1006

    Article  PubMed  CAS  Google Scholar 

  39. Swain JL, Sabina RL, Peyton RB et al. (1979) Derangements in myocardial purin and pyrimidin metabolism in patients with coronary artery disease and left ventricular hypertrophy. Proc Natl Acad Sci USA 79:655–659

    Article  Google Scholar 

  40. Thierfelder L, Holubarsch C, Hasenfuss G, Heiss HW, Just H (1991) The effect of the partial beta-1-adrenoceptor agonist xamoterol on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy. J Cardiovasc Pharmacol 17:593–599

    Article  PubMed  CAS  Google Scholar 

  41. von Herrath M, Hasenfuss G, Holubarsch C, Hofmann T, Heiss HW, Just H (1990) Repeated determination of left ventricular wall thickness from mass and volume during one cardiac cycle for the calculation of left ventricular wall stress parameters. Clin Cardiol 13:218–220

    Article  Google Scholar 

  42. Viquerat CE, Kereiakes D, Morris L, Daly PA, Wexman M, Frank P, Parmley WW, Chatterjee K (1985) Alterations in left ventricular function, coronary hemodynamics and myocardial catecholamine balance with MDL 17043, a new inotropic vasodilator agent, in patients with severe heart failure. J Am Coll Cardiol 5:326–332

    Article  PubMed  CAS  Google Scholar 

  43. Xamoterol in Severe Heart Failure Study Group (1990) Xamoterol in severe heart failure. Lancet 336:1–6

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Holubarsch, C., Hasenfuss, G., Just, H. (1993). Myocardial Oxygen Consumption in Patients with Idiopathic Dilated Cardiomyopathy: Effects of Vasodilating and Inotropic Agents. In: Figulla, HR., Kandolf, R., McManus, B. (eds) Idiopathic Dilated Cardiomyopathy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77891-9_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77891-9_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-77893-3

  • Online ISBN: 978-3-642-77891-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics